Cargando…

Severe Electrolyte Disturbances Due to Proton Pump Inhibitor Therapy: An Underrecognized Problem with Potentially Severe Sequelae

Patient: Female, 55-year-old Final Diagnosis: Convulsions and confusion due to electrolyte disturbances Symptoms: Confusion • convulsions Medication: — Clinical Procedure: — Specialty: Gastroenterology and Hepatology OBJECTIVE: Unusual clinical course BACKGROUND: Proton pump inhibitors are increasin...

Descripción completa

Detalles Bibliográficos
Autor principal:	Tagboto, Senyo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295188/ https://www.ncbi.nlm.nih.gov/pubmed/35836357 http://dx.doi.org/10.12659/AJCR.936893

Ejemplares similares

Effects of proton pump inhibitors and electrolyte disturbances on arrhythmias
por: El-Charabaty, Elie, et al.
Publicado: (2013)

Drug–drug interactions with proton pump inhibitors in cancer patients: an underrecognized cause of treatment failure
por: Raoul, J.L., et al.
Publicado: (2023)

Hepatocellular Carcinoma Presenting as Right Shoulder Pain
por: Tagboto, Senyo
Publicado: (2023)

Problems Associated with Deprescribing of Proton Pump Inhibitors
por: Helgadottir, Holmfridur, et al.
Publicado: (2019)

Association between proton pump inhibitors and periodontal disease severity
por: Chawla, Bhavneet K., et al.
Publicado: (2021)

Proton-pump inhibitor use amongst patients with severe hypomagnesemia
por: Seah, Sherry, et al.
Publicado: (2023)

Chronic Morel-Lavallée Lesion in a Pediatric Patient: An Underrecognized Sequela after Trauma
por: Kamson, Anthony O., et al.
Publicado: (2023)

Fibrillary glomerulonephritis with small fibrils in a patient with the antiphospholipid antibody syndrome successfully treated with immunosuppressive therapy
por: Javaid, Muhammad M, et al.
Publicado: (2007)

Proton pump inhibitors increase the severity of hepatic encephalopathy in cirrhotic patients
por: Fasullo, Matthew, et al.
Publicado: (2019)

Acute interstitial nephritis due to proton pump inhibitors
por: Sampathkumar, K., et al.
Publicado: (2013)

Sleep Disturbance Severity and Correlates in Post-acute Sequelae of COVID-19 (PASC)
por: Pena-Orbea, Cinthya, et al.
Publicado: (2023)

Progressive dyspnoea following the treatment of Mycobacterium abscessus infection in an individual with relapsing granulamatosis with polyangitis (Wegener’s), complicated by hearing loss requiring cochlear implantation
por: Tagboto, Senyo K, et al.
Publicado: (2012)

Unusual Neurological Manifestation of Proton Pump Inhibitor: A Case Report of Acute Disseminated Encephalomyelitis and Severe Hyponatremia After Brief Use of Proton Pump Inhibitor
por: Qureshi, Ahmad S, et al.
Publicado: (2021)

Stratification of Acute Kidney Injury Risk, Disease Severity, and Outcomes by Electrolyte Disturbances
por: Erfurt, Stefan, et al.
Publicado: (2023)

Proton pump inhibitors and the risk of severe cognitive impairment: The role of posttraumatic stress disorder
por: Clouston, Sean A.P., et al.
Publicado: (2017)

Persistent severe hypomagnesemia caused by proton pump inhibitor resolved after laparoscopic fundoplication
por: Semb, Synne, et al.
Publicado: (2017)

Proton-pump Inhibitor-induced Severe Hypomagnesemia and Hypocalcemia are Clinically Masked by Thiazide Diuretic
por: Uehara, Atsuko, et al.
Publicado: (2019)

Reduced gastric acidity, proton pump inhibitors and increased severity of COVID-19 infections
por: Price, Elizabeth, et al.
Publicado: (2021)

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023)

Disturbance in the oropharyngeal microbiota in relation to antibiotic and proton pump inhibitor medication and length of hospital stay
por: Tranberg, Anna, et al.
Publicado: (2020)

Selective IgA Deficiency May Be an Underrecognized Risk Factor for Severe COVID-19
por: Ameratunga, Rohan, et al.
Publicado: (2023)

Electrolyte and Acid-Base Disturbances Induced by Clacineurin Inhibitors
por: Lee, Chang Hwa, et al.
Publicado: (2007)

Blood electrolyte disturbances during severe hypoglycemia in Korean patients with type 2 diabetes
por: Kang, Mi Yeon
Publicado: (2015)

Multi-electrolyte disturbance and supplementation in severely malnourished hospitalized adolescents with restrictive eating disorders
por: Dunbar, Eva-Molly Petitto, et al.
Publicado: (2023)

Effect of Proton Pump Inhibitors on In Vitro Activity of Tigecycline against Several Common Clinical Pathogens
por: Ni, Wentao, et al.
Publicado: (2014)

802. Proton Pump Inhibitors Increase Clostridioides difficile Disease Severity Controlling for Infecting Strains
por: Fallatah, Saad, et al.
Publicado: (2020)

What is the role of proton pump inhibitors consumption on the clinical presentation and severity of COVID-19 infection?
por: Shokri, M.A., et al.
Publicado: (2023)

Proton Pump Inhibitor use in Hospitalized Patients: Is Overutilization Becoming a Problem?
por: Durand, Cheryl, et al.
Publicado: (2012)

Severe neurological sequelae and behaviour problems after cerebral malaria in Ugandan children
por: Idro, Richard, et al.
Publicado: (2010)

Proton Pump Inhibitors and Gastritis
por: Suzuki, Masayuki, et al.
Publicado: (2008)

Proton pump inhibitors and gastroenteritis
por: Hassing, Robert-Jan, et al.
Publicado: (2016)

Deprescribing proton pump inhibitors
por: Teh, Kim Jun Kevin, et al.
Publicado: (2023)

Rebuilding trust in proton pump inhibitor therapy
por: Turshudzhyan, Alla, et al.
Publicado: (2022)

Proton pump inhibitors display anti‐tumour potential in glioma
por: Li, Bihan, et al.
Publicado: (2022)

Recent effectiveness of proton pump inhibitors for severe reflux esophagitis: the first multicenter prospective study in Japan
por: Mizuno, Hideki, et al.
Publicado: (2015)

A Case of Severe Iron Deficiency Anemia Associated with Long-Term Proton Pump Inhibitor Use
por: Dado, David N., et al.
Publicado: (2017)

Disease severity and proton pump inhibitor use impact strongest on faecal microbiome composition in liver cirrhosis
por: Stadlbauer, Vanessa, et al.
Publicado: (2020)

Proton pump inhibitor on susceptibility to COVID-19 and its severity: a systematic review and meta-analysis
por: Pranata, Raymond, et al.
Publicado: (2021)

Intravascular Talcosis due to Intravenous Drug Use Is an Underrecognized Cause of Pulmonary Hypertension
por: Griffith, Christopher C., et al.
Publicado: (2012)

Analysis of postmarketing safety data for proton-pump inhibitors reveals increased propensity for renal injury, electrolyte abnormalities, and nephrolithiasis
por: Makunts, Tigran, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dd33kvj9f0de29nm53g7qpdfk8